Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $artv

ARTV sees a surge in social media activity with a XXX% increase in posts. The company's lead therapy, AlloNK, has received FDA Fast Track designation, driving positive sentiment.

### About $artv
ARTV is a biotechnology company focused on developing natural killer (NK) cell-based therapies.  

### Insights
- $artv posts created is up XXX% from the previous week.

### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$artv/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$artv/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXX  
X Week: XXXXX -XX%  
X Month: XXXXXX -XX%  
X Months: XXXXXXXXX +138%  
X Year: XXXXXXXXX +675%  
1-Year High: XXXXXXX on 2025-10-17  
1-Year Low: X on 2025-10-03  

Engagements by network (24h):
X: XXX

  
  
### Mentions: X (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$artv/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$artv/time-series/posts_active.tsv)  
Current Value: X  
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX -XX%  
X Months: XXXXX +988%  
X Year: XXXXX +3,430%  
1-Year High: XXXXX on 2025-10-20  
1-Year Low: X on 2025-10-03  

Mentions by network (24h):
X: XX

  
  
### Creators: X (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$artv/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$artv/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $artv in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: XX  
X Week: XX -XXXX%  
X Month: XXX -XX%  
X Months: XXXXX +3,061%  
X Year: XXXXX +4,210%  
1-Year High: XXXXX on 2025-10-20  
1-Year Low: X on 2025-10-03  

The most influential creators that mention $artv in the last XX hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@MarketCap_Live](/creator/twitter/MarketCap_Live) | X    | XXX       | X     | XXX         |

[View More](/list/creators/$artv/100)
  
  
### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$artv/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$artv/time-series/sentiment.tsv)  
Current Value: XXX%  
Daily Average: XX%  
X Week: XXX% no change  
X Month: XXX% no change  
X Months: XXX% no change  
X Year: XXX% no change  
1-Year High: XXX% on 2024-12-11  
1-Year Low: XX% on 2025-09-09  

Most Supportive Themes:
- FDA Fast Track Designation: (45%) ARTV's lead therapy, AlloNK, has received FDA Fast Track designation for the treatment of refractory rheumatoid arthritis.
- Biotech Catalyst Watchlist: (25%) ARTV has been identified on a watchlist for potential biotech catalysts, indicating anticipated future developments.
  
Most Critical Themes:
- Potential Pullback Risk: (10%) Some market observers suggest a risk of a price pullback following recent gains, with concerns that the positive news may be overemphasized.
  

### Top $artv Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"After Hours All Caps - Dec X Gainers Losers $ATMC +460% $TWG -XX% $XCUR +81% $ORKT -XX% $NCPL +58% $CEP -XX% $ATMV +43% $BDRX -XX% $ALEX +37% $MHUA -XX% $GIPR +37% $CETX -XX% $RDAC +32% $JXG -XX% $BTTC +20% $YAAS -XX% $MAMA +17% $ALM -XX% $CHR +14% $GURE -XX% $ARTV +13% $PTHL -XXX% $INEO +11% $WHLR -XXX% $AKA +11% $ISPC -XXX% $KXIN +11% $GV -XXX% $SAIH +9.4% $CCTG -8.4%"  
[X Link](https://x.com/MarketCap_Live/status/1998187610305647047) [@MarketCap_Live](/creator/x/MarketCap_Live) 2025-12-09T00:27Z XXX followers, XXX engagements


"After Hours Microcaps (Under $200M) - Dec X Gainers Losers $ATMC +460% $TWG -XX% $XCUR +81% $ORKT -XX% $NCPL +58% $CEP -XX% $ATMV +43% $BDRX -XX% $GIPR +37% $MHUA -XX% $RDAC +32% $CETX -XX% $BTTC +20% $JXG -XX% $CHR +14% $YAAS -XX% $ARTV +13% $GURE -XX% $INEO +11% $PTHL -XXX% $AKA +11% $WHLR -XXX% $KXIN +11% $ISPC -XXX% $SAIH +9.4% $GV -XXX% $IOTR +9.2% $CCTG -XXX% $NCI +9% $TIRX -8.4%"  
[X Link](https://x.com/MarketCap_Live/status/1998187562217967926) [@MarketCap_Live](/creator/x/MarketCap_Live) 2025-12-09T00:26Z XXX followers, XXX engagements


"RA Capital Q325 13F Recap: (2/3) Unchanged: $ABOS $ACET $ACLX $ACRV $ARTV $ASND $BCAX $CDTX $CTMX $DNTH $ELDN $ELYM $ETNB $FDMT $FULC $GERN $GPCR $GHRS $HOWL $IFRX $IRON $JANX $JBIO $LENZ $LRMR $MNPR $MTSR $NAMS $NAMSW $NKTX $PCSC $PCVX $RCUS"  
[X Link](https://x.com/seedytx19/status/1992339506725556704) [@seedytx19](/creator/x/seedytx19) 2025-11-22T21:08Z 1342 followers, 1126 engagements


"OTC plays with clean balance sheets rarely stay this quiet. $BFCH = $XXX M MC vs. $X M acquisition target $XXXX fixed share benchmark new leadership and no debt. @bfchco @DrBalencic $ERNA $FGC $FRGT $DVLT $XHLD $CODX $TGL $CLIK $BKYI $ASST $MAMK"  
[X Link](https://x.com/SmallCapGrowthX/status/1983603672698491059) [@SmallCapGrowthX](/creator/x/SmallCapGrowthX) 2025-10-29T18:35Z 3786 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$artv

ARTV sees a surge in social media activity with a XXX% increase in posts. The company's lead therapy, AlloNK, has received FDA Fast Track designation, driving positive sentiment.

About $artv

ARTV is a biotechnology company focused on developing natural killer (NK) cell-based therapies.

Insights

  • $artv posts created is up XXX% from the previous week.

Engagements: XXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XX%
X Months: XXXXXXXXX +138%
X Year: XXXXXXXXX +675%
1-Year High: XXXXXXX on 2025-10-17
1-Year Low: X on 2025-10-03

Engagements by network (24h): X: XXX

Mentions: X (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXXXX +988%
X Year: XXXXX +3,430%
1-Year High: XXXXX on 2025-10-20
1-Year Low: X on 2025-10-03

Mentions by network (24h): X: XX

Creators: X (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $artv in the last XX hours which is down XX% from X in the previous XX hours Daily Average: XX
X Week: XX -XXXX%
X Month: XXX -XX%
X Months: XXXXX +3,061%
X Year: XXXXX +4,210%
1-Year High: XXXXX on 2025-10-20
1-Year Low: X on 2025-10-03

The most influential creators that mention $artv in the last XX hours

Creator Rank Followers Posts Engagements
@MarketCap_Live X XXX X XXX

View More

Sentiment: XXX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% no change
X Month: XXX% no change
X Months: XXX% no change
X Year: XXX% no change
1-Year High: XXX% on 2024-12-11
1-Year Low: XX% on 2025-09-09

Most Supportive Themes:

  • FDA Fast Track Designation: (45%) ARTV's lead therapy, AlloNK, has received FDA Fast Track designation for the treatment of refractory rheumatoid arthritis.
  • Biotech Catalyst Watchlist: (25%) ARTV has been identified on a watchlist for potential biotech catalysts, indicating anticipated future developments.

Most Critical Themes:

  • Potential Pullback Risk: (10%) Some market observers suggest a risk of a price pullback following recent gains, with concerns that the positive news may be overemphasized.

Top $artv Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"After Hours All Caps - Dec X Gainers Losers $ATMC +460% $TWG -XX% $XCUR +81% $ORKT -XX% $NCPL +58% $CEP -XX% $ATMV +43% $BDRX -XX% $ALEX +37% $MHUA -XX% $GIPR +37% $CETX -XX% $RDAC +32% $JXG -XX% $BTTC +20% $YAAS -XX% $MAMA +17% $ALM -XX% $CHR +14% $GURE -XX% $ARTV +13% $PTHL -XXX% $INEO +11% $WHLR -XXX% $AKA +11% $ISPC -XXX% $KXIN +11% $GV -XXX% $SAIH +9.4% $CCTG -8.4%"
X Link @MarketCap_Live 2025-12-09T00:27Z XXX followers, XXX engagements

"After Hours Microcaps (Under $200M) - Dec X Gainers Losers $ATMC +460% $TWG -XX% $XCUR +81% $ORKT -XX% $NCPL +58% $CEP -XX% $ATMV +43% $BDRX -XX% $GIPR +37% $MHUA -XX% $RDAC +32% $CETX -XX% $BTTC +20% $JXG -XX% $CHR +14% $YAAS -XX% $ARTV +13% $GURE -XX% $INEO +11% $PTHL -XXX% $AKA +11% $WHLR -XXX% $KXIN +11% $ISPC -XXX% $SAIH +9.4% $GV -XXX% $IOTR +9.2% $CCTG -XXX% $NCI +9% $TIRX -8.4%"
X Link @MarketCap_Live 2025-12-09T00:26Z XXX followers, XXX engagements

"RA Capital Q325 13F Recap: (2/3) Unchanged: $ABOS $ACET $ACLX $ACRV $ARTV $ASND $BCAX $CDTX $CTMX $DNTH $ELDN $ELYM $ETNB $FDMT $FULC $GERN $GPCR $GHRS $HOWL $IFRX $IRON $JANX $JBIO $LENZ $LRMR $MNPR $MTSR $NAMS $NAMSW $NKTX $PCSC $PCVX $RCUS"
X Link @seedytx19 2025-11-22T21:08Z 1342 followers, 1126 engagements

"OTC plays with clean balance sheets rarely stay this quiet. $BFCH = $XXX M MC vs. $X M acquisition target $XXXX fixed share benchmark new leadership and no debt. @bfchco @DrBalencic $ERNA $FGC $FRGT $DVLT $XHLD $CODX $TGL $CLIK $BKYI $ASST $MAMK"
X Link @SmallCapGrowthX 2025-10-29T18:35Z 3786 followers, XXX engagements

$artv
/topic/$artv